These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31098947)

  • 1. Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.
    Walker S; Griffin S; Asaria M; Tsuchiya A; Sculpher M
    Appl Health Econ Health Policy; 2019 Oct; 17(5):577-590. PubMed ID: 31098947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the societal perspective in cost-effectiveness analysis useful for decision makers?
    Russell LB; Fryback DG; Sonnenberg FA
    Jt Comm J Qual Improv; 1999 Sep; 25(9):447-54. PubMed ID: 10481813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation in cardiology.
    Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the value of treating schizophrenia?
    Carr VJ; Lewin TJ; Neil AL
    Aust N Z J Psychiatry; 2006; 40(11-12):963-71. PubMed ID: 17054564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five pillars for societal perspective.
    Drost RMWA; Paulus ATG; Evers SMAA
    Int J Technol Assess Health Care; 2020 Apr; 36(2):72-74. PubMed ID: 32000868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel set of Austrian reference unit costs for comprehensive societal perspectives consistent with latest European costing methods for economic evaluations.
    Berger M; Mayer S; Simon J
    Wien Klin Wochenschr; 2024 Jan; 136(1-2):1-12. PubMed ID: 36564501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector.
    Longo F; Claxton K; Griffin S; Mason A; Walker S; Weatherly H
    Value Health; 2024 Jul; 27(7):823-829. PubMed ID: 38316357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
    Hoomans T; Fenwick EA; Palmer S; Claxton K
    Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross-sectoral analysis of an alcohol misuse intervention.
    Ramponi F; Walker S; Griffin S; Parrott S; Drummond C; Deluca P; Coulton S; Kanaan M; Richardson G
    Health Econ; 2021 May; 30(5):972-988. PubMed ID: 33604984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.
    Franklin M; Lomas J; Richardson G
    Pharmacoeconomics; 2020 Jul; 38(7):665-681. PubMed ID: 32291596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation as institution: a contractarian argument for needs-based economic evaluation.
    Rogowski WH
    BMC Med Ethics; 2018 Jun; 19(1):59. PubMed ID: 29895268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty.
    Sendi P; Al MJ
    Soc Sci Med; 2003 Sep; 57(6):969-74. PubMed ID: 12878098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of illness and economic evaluation in rare diseases.
    López-Bastida J; Oliva-Moreno J
    Adv Exp Med Biol; 2010; 686():273-82. PubMed ID: 20824451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging the gap between the economic evaluation literature and daily practice in occupational health: a qualitative study among decision-makers in the healthcare sector.
    van Dongen JM; Tompa E; Clune L; Sarnocinska-Hart A; Bongers PM; van Tulder MW; van der Beek AJ; van Wier MF
    Implement Sci; 2013 Jun; 8():57. PubMed ID: 23731570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What care is 'essential'? What services are 'basic'?
    Eddy DM
    JAMA; 1991 Feb; 265(6):782, 786-8. PubMed ID: 1899277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of summer programmes on the outcomes of disadvantaged or 'at risk' young people: A systematic review.
    Muir D; Orlando C; Newton B
    Campbell Syst Rev; 2024 Jun; 20(2):e1406. PubMed ID: 38873396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy.
    Sendi P
    Int J Health Care Finance Econ; 2008 Jun; 8(2):113-21. PubMed ID: 18351456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.